Lurasidone

Common brands: Latuda, Lamictal Xr, Lamictal Odt, Lamictal, Abilify

Top reporter: Sumitomo Pharma America, Inc.

Atypical Antipsychotic [EPC]Benzodiazepine [EPC]Anti-epileptic Agent [EPC]Mood Stabilizer [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
20,655
Total Reports
5,324
Serious Reports
572
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.77%)

Patient Demographics

Male
4,880
Female
11,374

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lurasidone.

# Reaction Reports % of Total
1 OFF LABEL USE 2,062
8.3%
2 DRUG INEFFECTIVE 1,846
7.4%
3 ANXIETY 1,233
5.0%
4 FEELING ABNORMAL 1,168
4.7%
5 DEPRESSION 1,131
4.6%
6 WEIGHT INCREASED 1,091
4.4%
7 SOMNOLENCE 1,072
4.3%
8 NAUSEA 1,046
4.2%
9 INSOMNIA 1,012
4.1%
10 SUICIDAL IDEATION 968
3.9%
11 FATIGUE 947
3.8%
12 DYSKINESIA 825
3.3%
13 SUICIDE ATTEMPT 759
3.1%
14 TREMOR 708
2.9%
15 VOMITING 674
2.7%
16 MALAISE 660
2.7%
17 SEDATION 618
2.5%
18 RESTLESSNESS 603
2.4%
19 CONDITION AGGRAVATED 601
2.4%
20 BLOOD GLUCOSE INCREASED 587
2.4%
21 DYSTONIA 571
2.3%
22 AKATHISIA 569
2.3%
23 MANIA 569
2.3%
24 TARDIVE DYSKINESIA 562
2.3%
25 DIZZINESS 549
2.2%
26 HEADACHE 527
2.1%
27 SEXUAL DYSFUNCTION 483
1.9%
28 SCHIZOPHRENIA 468
1.9%
29 THERAPY CESSATION 449
1.8%
30 AGITATION 448
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.